Organ Transplant in the Direct-acting Antiviral Era

The CDC update recommends ending screening strategies that require multiple clinic visits for sample collection, favoring 1 visit and automatic HCV RNA testing.

Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.

Direct-acting antiviral treatment was independently associated with a lower risk of mortality and liver and nonliver outcomes in a large study of adults with chronic hepatitis C.

Timely initiation of DAA treatment, regardless of insurance type, is crucial in reducing HCV-related death, disparity, and transmission, concluded CDC researchers.

IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.

The American College of Physicians urges clinicians to make sure adult patients, especially the most vulnerable, are protected against preventable diseases as COVID spreads and flu is imminent.